Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Targeted Drugs for Breast Cancer Market Status and Forecast (2016-2027)
1.3.2 Global Targeted Drugs for Breast Cancer Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Targeted Drugs for Breast Cancer Supply by Company
2.1 Global Targeted Drugs for Breast Cancer Sales Value by Company
2.2 Targeted Drugs for Breast Cancer Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Targeted Drugs for Breast Cancer Market Status by Type
3.1 Targeted Drugs for Breast Cancer Type Introduction
3.1.1 HER-2 Targeted Drugs
3.1.2 CDK4/6 Inhibitors
3.1.3 PARP Targeted Drugs
3.1.4 PI3K/AKT/mTor Pathway Inhibitors
3.1.5 ER Targeted Drugs
3.1.6 Aromatase Inhibitors
3.1.7 Tubulin Inhibitors
3.1.8 VEGF Targeted Drugs
3.1.9 YTMS Targeted Drugs
3.1.10 Other
3.2 Global Targeted Drugs for Breast Cancer Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Targeted Drugs for Breast Cancer Market Status by Application
4.1 Targeted Drugs for Breast Cancer Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Drug Center
4.1.4 Other
4.2 Global Targeted Drugs for Breast Cancer Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Targeted Drugs for Breast Cancer Market Status by Region
5.1 Global Targeted Drugs for Breast Cancer Market by Region
5.2 North America Targeted Drugs for Breast Cancer Market Status
5.3 Europe Targeted Drugs for Breast Cancer Market Status
5.4 Asia Pacific Targeted Drugs for Breast Cancer Market Status
5.5 Central & South America Targeted Drugs for Breast Cancer Market Status
5.6 Middle East & Africa Targeted Drugs for Breast Cancer Market Status
6 North America Targeted Drugs for Breast Cancer Market Status
6.1 North America Targeted Drugs for Breast Cancer Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Targeted Drugs for Breast Cancer Market Status
7.1 Europe Targeted Drugs for Breast Cancer Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Targeted Drugs for Breast Cancer Market Status
8.1 Asia Pacific Targeted Drugs for Breast Cancer Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Targeted Drugs for Breast Cancer Market Status
9.1 Central & South America Targeted Drugs for Breast Cancer Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Targeted Drugs for Breast Cancer Market Status
10.1 Middle East & Africa Targeted Drugs for Breast Cancer Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Targeted Drugs for Breast Cancer Market Forecast by Type and by Application
12.1 Global Targeted Drugs for Breast Cancer Sales Value Forecast (2022-2027)
12.2 Global Targeted Drugs for Breast Cancer Forecast by Type
12.3 Global Targeted Drugs for Breast Cancer Forecast by Application
13 Global Targeted Drugs for Breast Cancer Market Forecast by Region/Country
13.1 Global Targeted Drugs for Breast Cancer Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Teva
14.1.1 Company Information
14.1.2 Targeted Drugs for Breast Cancer Product Introduction
14.1.3 Teva Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Roche
14.2.1 Company Information
14.2.2 Targeted Drugs for Breast Cancer Product Introduction
14.2.3 Roche Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Reliance Group
14.3.1 Company Information
14.3.2 Targeted Drugs for Breast Cancer Product Introduction
14.3.3 Reliance Group Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Puma Biotechnology
14.4.1 Company Information
14.4.2 Targeted Drugs for Breast Cancer Product Introduction
14.4.3 Puma Biotechnology Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Pfizer
14.5.1 Company Information
14.5.2 Targeted Drugs for Breast Cancer Product Introduction
14.5.3 Pfizer Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Otsuka Pharmaceutical
14.6.1 Company Information
14.6.2 Targeted Drugs for Breast Cancer Product Introduction
14.6.3 Otsuka Pharmaceutical Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Novartis
14.7.1 Company Information
14.7.2 Targeted Drugs for Breast Cancer Product Introduction
14.7.3 Novartis Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Mylan
14.8.1 Company Information
14.8.2 Targeted Drugs for Breast Cancer Product Introduction
14.8.3 Mylan Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Merck
14.9.1 Company Information
14.9.2 Targeted Drugs for Breast Cancer Product Introduction
14.9.3 Merck Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Hikma
14.10.1 Company Information
14.10.2 Targeted Drugs for Breast Cancer Product Introduction
14.10.3 Hikma Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 Hetero
14.12 Hengrui Pharmaceutical
14.13 Hengrui Medicine
14.14 GlaxoSmithKline
14.15 Eli Lilly
14.16 Eisai
14.17 Cipla
14.18 Chugai Pharmaceutical
14.19 CANbridge
14.20 Bristol-Myers Squibb
14.21 BioMarin
14.22 Beijing Biostar Technologies
14.23 Bayer
14.24 AstraZeneca
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Targeted Drugs for Breast Cancer Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Targeted Drugs for Breast Cancer Sales Value (Million USD) by Company (2019-2021)
Table Global Targeted Drugs for Breast Cancer Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Targeted Drugs for Breast Cancer Sales Area
Table Targeted Drugs for Breast Cancer Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table Global Targeted Drugs for Breast Cancer Sals Value Market Share by Type (2016-2021)
Table North America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table North America Targeted Drugs for Breast Cancer Sales Value Market Share by Type (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Sales Value Market Share by Type (2016-2021)
Table Central & South America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Targeted Drugs for Breast Cancer Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Sales Value Market Share by Type (2016-2021)
Table Global Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table Global Targeted Drugs for Breast Cancer Value Market Share by Application (2016-2021)
Table North America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table North America Targeted Drugs for Breast Cancer Sales Value Market Share by Application (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Sales Value Market Share by Application (2016-2021)
Table Central & South America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Targeted Drugs for Breast Cancer Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Sales Value Market Share by Application (2016-2021)
Table Global Targeted Drugs for Breast Cancer Sales Value (Million USD) by Region (2016-2021)
Table Global Targeted Drugs for Breast Cancer Value Market Share by Region (2016-2021)
Table North America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Country (2016-2021)
Table North America Targeted Drugs for Breast Cancer Value Market Share by Country (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Sales Value (Million USD) by Country (2016-2021)
Table Europe Targeted Drugs for Breast Cancer Value Market Share by Country (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Targeted Drugs for Breast Cancer Value Market Share by Country (2016-2021)
Table Central & South America Targeted Drugs for Breast Cancer Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Targeted Drugs for Breast Cancer Value Market Share by Country (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Targeted Drugs for Breast Cancer Value Market Share by Country (2016-2021)
Table Global Targeted Drugs for Breast Cancer Value (Million USD) Forecast by Type (2022-2027)
Table Global Targeted Drugs for Breast Cancer Value Market Share Forecast by Type (2022-2027)
Table Global Targeted Drugs for Breast Cancer Value (Million USD) Forecast by Application (2022-2027)
Table Global Targeted Drugs for Breast Cancer Value Market Share Forecast by Application (2022-2027)
Table Global Targeted Drugs for Breast Cancer Value (Million USD) Forecast by Region (2022-2027)
Table Global Targeted Drugs for Breast Cancer Value Market Share Forecast by Region (2022-2027)
Table Teva Company Information
Table Teva Product Introduction
Table Teva Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Roche Company Information
Table Roche Product Introduction
Table Roche Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Reliance Group Company Information
Table Reliance Group Product Introduction
Table Reliance Group Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Puma Biotechnology Company Information
Table Puma Biotechnology Product Introduction
Table Puma Biotechnology Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Pfizer Company Information
Table Pfizer Product Introduction
Table Pfizer Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Otsuka Pharmaceutical Company Information
Table Otsuka Pharmaceutical Product Introduction
Table Otsuka Pharmaceutical Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Novartis Company Information
Table Novartis Product Introduction
Table Novartis Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Mylan Company Information
Table Mylan Product Introduction
Table Mylan Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Merck Company Information
Table Merck Product Introduction
Table Merck Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)
Table Hikma Company Information
Table Hikma Product Introduction
Table Hikma Targeted Drugs for Breast Cancer Sales Value, Gross Margin and Global Share (2019-2021)